Ergoteles’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Ergoteles’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,273	Closed	-$244K	–	1164
2020 Q4	$244K	Buy	+13,273	New	+$242K	0.01%	565

Ergoteles's CBMG Position: Q1 2021 in Review

Ergoteles sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 13,273 shares — an estimated $244K sold.

Ergoteles first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $244K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Ergoteles reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Ergoteles sold 13,273 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $244K.
Ergoteles first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
Ergoteles's Cellular Biomedicine Group, Inc. position peaked at $244K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Ergoteles's 13F filing for Q1 2021, filed 12 May 2021.